Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Wheeler, Cosette M, Dr, Prof ; Castellsagué, Xavier, PhD ; Garland, Suzanne M, Prof ; Szarewski, Anne, PhD ; Paavonen, Jorma, Prof ; Naud, Paulo, Prof ; Salmerón, Jorge, Prof ; Chow, Song-Nan, Prof ; Apter, Dan, MD ; Kitchener, Henry, Prof ; Teixeira, Júlio C, MD ; Skinner, S Rachel, PhD ; Jaisamrarn, Unnop, Prof ; Limson, Genara, Prof ; Romanowski, Barbara, Prof ; Aoki, Fred Y, Prof ; Schwarz, Tino F, Prof ; Poppe, Willy A J, Prof ; Bosch, F Xavier, PhD ; Harper, Diane M, MD ; Huh, Warner, MD ; Hardt, Karin, PhD ; Zahaf, Toufik, PhD ; Descamps, Dominique, MD ; Struyf, Frank, MD ; Dubin, Gary, MD ; Lehtinen, Matti, Prof

The lancet oncology, 2012, Vol.13 (1), p.100-110 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível